[ad_1]
The European Medicines Agency (EMA) has received the first clinical trials of the Covid-19 vaccine and hopes to give its approval for a first cure for the new coronavirus by the end of the year. In this context, the dose distribution would start in January 2021.
“If the data is solid, we will be able to agree on a first vaccine by the end of the year and we will be able to begin its distribution in January,” EMA director Guido Rasi told AFP, quoted by Agerpres.
The mission of the Agency is to authorize and control medicines in the EU. The final agreement, granted by the European Commission, allows laboratories to market their medicines throughout the European Union.
EMA, which expects six or seven different vaccines to be available in 2021, a received “the first clinical data from Pfizer for its vaccine” on Friday, Guido Rasi said. “We have received preclinical data from AstraZeneca, those from animal tests are already being evaluated and we have also had several discussions with Moderna,” he said.
“If a vaccine is launched in January, its first effects on the spread of the virus will be visible in five or six months, mainly next summer.” explained the director of the EMA.
“Obviously, not everyone will be able to be vaccinated, but we will start with the most exposed categories, such as the elderly and health workers, who will begin to block transmission bridges,” added the official.
He believes that “more than half” of the European population needs to be vaccinated to “be able to witness a pandemic decline”, which will require “at least 500 million doses in Europe,” the cited source also writes.
To vaccinate everyone, “it will take at least a year”, and “if all goes well, by the end of 2021 we would have enough immunizations,” added Guido Rasi.
Publisher: AA
